Clinical trial
The IMPACT Study - Identification of Men With a Genetic Predisposition to…
NCT00261456 · Institute of Cancer Research, United Kingdom, Other · Active, not recruiting
Key facts
| NCT number | NCT00261456 |
|---|---|
| Title | The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer |
| Official title | The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer: Targeted Screening in Men at Higher Genetic Risk and Controls |
| Lead sponsor | Institute of Cancer Research, United Kingdom, Other |
| Collaborators | Cancer Research UK Royal Marsden NHS Foundation Trust Ronald and Rita McAulay Foundation BRCA Research and Cure Alliance |
| Status | Active, not recruiting |
| Study type | Observational |
| Conditions | Prostate Cancer, BRCA Mutation, Mismatch Repair Gene Mutation, Genetic Predisposition to Disease |
| Intervention type | Diagnostic Test, Procedure |
| Interventions | PSA test, Prostate Biopsy |
| Enrollment | 3,500 |
| Start date | Mar 1, 2005 |
| Primary completion | Feb 28, 2030 |
| Completion | Mar 1, 2030 |
| First posted | Dec 5, 2005 |
| Last update posted | Sep 26, 2025 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: